07:00 , Apr 6, 2015 |  BC Week In Review  |  Clinical News

AmpliVue Trichomonas Assay regulatory update

FDA granted 510(k) clearance for Quidel’s AmpliVue Trichomonas Assay to diagnose trichomoniasis from vaginal swabs from symptomatic or asymptomatic female patients. The product detects nucleic acids from Trichomonas vaginalis and is now available in the...